A patent-pending, research backed, E-paper secondary monitor to reduce the negative health repercussions of using LCD screens for individuals recovering from a concussion. The product also may offer benefits to individuals living with chronic migraines, or suffering from eyestrain.


Iris Technologies' product is a 13.3 inch secondary computer monitor that is designed to be used concurrently or as a substitute to an LCD screen. The monitor uses E-paper technology, which refreshes only when the content of the screen changes. It does not have the bright flashing pixels of an LCD screen and is not backlit. Iris’ secondary monitor thereby could reduce concussion symptoms found with LCD screen use. This then allows patients to reintroduce daily tasks and a level of productivity into their life. Even reconnecting with their digital social network matters a great deal in the recovery process. The monitor may also offer benefits to someone suffering from chronic migraines or from eye strain cause by long-term computer use. 


Colin Harding's role is the business development of Iris including the company’s marketing, sales, IP, and finances. He is an alumnus of the Smith School of Business at Queen's University.

Conor Ross

Conor Ross' role includes the development of Iris’ products, the company’s supply chain, and clinical research. He is an alumnus of Mechanical Engineering at Queen's University

Iris' management team gravitated to this idea because each co-founder has family members or close friends who have suffered from serious concussions that greatly affected their social and work lives. One of the largest barriers faced by these individuals in interacting with other people was the fact that computer screens were difficult to look at. For individuals who suffer from these medical conditions or who spend a long period of time working on LCD screens, Iris Technologies could alleviate some of these issues.

Our Partners